行情

MRK

MRK

默克
NYSE

实时行情|Nasdaq Last Sale

73.61
+0.56
+0.77%
盘后: 73.73 +0.12 +0.16% 19:39 09/24 EDT
开盘
73.59
昨收
73.05
最高
74.63
最低
73.35
成交量
1,471.47万
成交额
--
52周最高
85.60
52周最低
68.38
市值
1,863.34亿
市盈率(TTM)
38.96
分时
5日
1月
3月
1年
5年
到 2028 年具有关键驱动因素、趋势和机遇的口服疫苗市场研究报告
The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing companies' initiatives to enhance R&D, Newer and more expensive vaccines are coming into th...
Heraldkeepers · 11小时前
为什么这 10 只股票在周五上涨
In this article we will take a look at the some of notable stocks on the move today. You can skip our detailed analysis of these stocks and go to read Why These 5 Stocks Are on the Move on Friday. After yesterday’s big rally, the broader market is in the r...
Insider Monkey · 13小时前
午盘走势最大的股票:嘉年华、耐克、比赛等
These are the stocks posting the largest moves in midday trading.
CNBC.com · 14小时前
为什么阿斯利康股票今天交易更高
AstraZeneca (NASDAQ: AZN) shares are trading higher after the company announced lynparza PROpel trial met the primary endpoint in metastatic castration-resistant prostate cancer.
Benzinga · 16小时前
生长激素缺乏症市场:2028 年增长、新兴趋势和预测的行业洞察
Research Nester published a report titled  which delivers a detailed overview of the growth hormone deficiency market in terms of market segmentation by application, by route of administration, by distribution channel,  and by region.
AmericaNewsHour · 16小时前
到 2027 年,类器官市场将以高复合年增长率增长全球行业分析和预测 | COVID-19 大流行的影响
Research Nester released a report titled which delivers detailed overview of the global organoids market in terms of market segmentation by product, by application and by region.
AmericaNewsHour · 17小时前
BELLUS (BLU) 完成两项中期研究的注册
Zacks.com · 17小时前
行业更新:医疗保健股周五回落
MT Newswires · 17小时前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解MRK最新的财务预测,通过MRK每股收益,每股净资产,每股现金流等数据分析默克近期的经营情况,然后做出明智的投资选择。
分析师评级

23位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测MRK价格均价为92.43,最高价位107.00,最低价为80.00。
EPS
机构持股
总机构数: 3,291
机构持股: 20.03亿
持股比例: 79.13%
总股本: 25.31亿
类型机构数股数
增持
1,249
1.01亿
建仓
122
1,704.18万
减持
940
1.05亿
平仓
113
462.57万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.45%
制药与医学研究
-1.02%
高管信息
Chairman/Executive Director
Kenneth Frazier
President/Chief Executive Officer/Director
Robert Davis
Chief Financial Officer/Executive Vice President
Caroline Litchfield
Corporate Executive
Franklin Clyburn
Corporate Executive
Dean Li
Chief Human Resource Officer/Executive Vice President
Steven Mizell
Executive Vice President/General Counsel/Secretary
Jennifer Zachary
Executive Vice President
Sanat Chattopadhyay
Executive Vice President
Richard DeLuca
Executive Vice President
Julie Gerberding
Executive Vice President
Michael Klobuchar
Senior Vice President - Finance/Controller
Rita Karachun
Senior Vice President/Chief Compliance Officer
Michael Fleming
Other
Cristal Downing
Independent Director
Mary Coe
Independent Director
Pamela Craig
Independent Director
Thomas Glocer
Independent Director
Risa Lavizzo-Mourey
Independent Director
Stephen Mayo
Independent Director
Paul Rothman
Independent Director
Patricia Russo
Independent Director
Christine Seidman
Independent Director
Inge Thulin
Independent Director
Kathy Warden
Independent Director
Peter Wendell
公告日期
每股分红
除权日期
2021/07/27
每股分红:USD 0.65
2021/09/14
2021/05/25
每股分红:USD 0.65
2021/06/14
2021/01/26
每股分红:USD 0.65
2021/03/12
2020/11/17
每股分红:USD 0.65
2020/12/14
2020/07/28
每股分红:USD 0.61
2020/09/14
2020/05/26
每股分红:USD 0.61
2020/06/12
2020/01/28
每股分红:USD 0.61
2020/03/13
2019/11/19
每股分红:USD 0.61
2019/12/13
2019/07/23
每股分红:USD 0.55
2019/09/13
2019/05/28
每股分红:USD 0.55
2019/06/14
2019/01/29
每股分红:USD 0.55
2019/03/14
2018/10/25
每股分红:USD 0.55
2018/12/14
2018/07/24
每股分红:USD 0.48
2018/09/14
2018/05/22
每股分红:USD 0.48
2018/06/14
2018/01/23
每股分红:USD 0.48
2018/03/14
2017/11/28
每股分红:USD 0.48
2017/12/14
2017/07/26
每股分红:USD 0.47
2017/09/14
2017/05/23
每股分红:USD 0.47
2017/06/13
2017/03/01
每股分红:USD 0.47
2017/03/13
2016/11/22
每股分红:USD 0.47
2016/12/13
MRK 简况
Merck & Co., Inc.是一家全球保健公司。该公司通过直接销售及由合营公司销售处方药、疫苗、生物治疗药品及动物保健产品提供保健解决方案。该公司通过药品部门运营。该部门直接销售或通过合营公司销售人体健康医药及疫苗产品。人体健康医药产品包括用于治疗人体疾病的治疗剂及预防剂(通常为处方药)。该公司主要向药品批发商及零售商、医院、政府机构和受管制的医疗服务商销售其人体健康医药产品。动物保健部门研究、开发、制造及销售疫苗等动物保健产品。该公司向兽医诊所、分销商及农畜生产商销售动物保健产品。

微牛提供Merck & Co., Inc.(NYSE-MRK)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的MRK股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MRK股票基本功能。